Introduction
The Power of a Second Opinion: The power of a Medical Second opinion when faced with a serious medical diagnosis for yourself or a loved one cannot be overstated. Yet, finding a qualified medical professional to provide this critical perspective can be challenging.
The Need: 2MDOpinion addresses this challenge with a clear mission: helping those who are in need of a second medical opinion worldwide.
Global Network: Access to over 100 medical specialists and specialties.
Comprehensive Expertise: Specialists available across a wide range of medical fields.
Patient-Centric Approach: Designed for individuals seeking the reassurance of a well-informed medical decision in their own language or availability of alternate treatment plans. 2MDOpinion is dedicated to making expert opinions available to everyone, regardless of location or language.
Worldwide Reach: Medical specialists accessible to patients across the globe.
Seamless Communication: Enhanced by IBM AI instant language translation and automatic generation of EMR reports, breaking down language barriers and improving accessibility.
With 2MDOpinion, patients and their families gain peace of mind, knowing they have access to the best possible guidance when making important medical decisions.
Success to Date
- TCE Group* has launched in Canada and in Egypt.
- TCE Group provided services to over seventy patients through relationships with local clinics and US specialists.
- TCE Group is in discussions with a multi clinic business in Egypt to use TCE Group’s Echo technology.
- There are current efforts to expand 2MDOpinion into Saudi Arabia, Jordan and the UAE.
*TCE Group, a Canadian company that is solely owned by Amr Bannis (CEO of the Company), is an IBM business partner that uses watsonx.AI impeded technology in TCE Group's Echo technology for instant audio translation and automatic medical report generation. TCE Group owns the Echo technology and plans to license it to the Company.
Problem
Patients with serious medical diagnosis normally have multiple options of treatments each with its own benefits, risks and cost or insurance coverage. Every patient is seeking the best option that suits his/her particular medical and personal case. Finding the right medical specialist to confirm or suggest the best alternative treatment in a convenient & short time is often challenging. Normally patients have limited access to alternative treatment options within their geographical location. Also, connecting specialists in different languages or different time zones limits the patients’ access and makes providing medical service prohibitive.
Solution
The increasing complexity and severity of chronic diseases is compelling patients to seek second opinions from other physicians and healthcare experts to ensure proper diagnosis and optimal treatment plans. This is resulting in rising demand for medical second opinions.
The cancer segment dominated the medical second opinion market in 2024 and is expected to continue its dominance over the forecast period. Rising prevalence of various types of cancers such as lung cancer, breast cancer, prostate cancer, colorectal cancer and others is a key factor driving the segment. As per the WHO, cancer burden has risen to 18.1 million new cases and 9.6 million cancer deaths in 2018. Growing awareness about seeking second opinions for complex cancer cases is also contributing to the growth of this segment.
2MDOpinion provides patients with convenient access to global specialists resolving complex appointment scheduling, using IBM watsonx.AI to automatically generate EMR medical reports and provides AI language translation, unlike competitor’s solution offered in one language in local regions with a limited number of specialists. With 100 languages supported and more than 50 specialities, the services reach is much higher than comparable services. Also, health insurance providers are encouraging the use of second medical opinions to avoid unnecessary medical interventions and curb healthcare costs.
In addition, 2MDOpinion offers triage support to patients helping them identify the most appropriate specialists to their medical case. Such convenience increases patients’ adoption and upsells other services such as medical tourism and offshore treatment generating additional higher value commissions & revenue.
Commercializing our language translation and automatic generation of EMR reports as a service directly to clinics, hospitals and physicians may generate additional high revenue streams as it can save clinicians 8 minutes per each encounter and up to 160 minutes per day.
Business Model
Revenue streams are generated from these areas:
- 30% Fees already charged for doctor appointments with potential subscription fees planned in the future or additional usage fee once application passed BETA testing
- Other planned fees are: language translation services fees, referral commission fees, fees to doctors for EMR report generation.
On a global basis, anyone that determines that a second medical opinion is of interest can achieve the goal by contacting 2MDOpinion.com.
Team
He is leading business development globally and leading the NTG Health Solutions line of business and AI solutions and is partner of several Health Service companies and other companies.
Gamal has held progressively senior positions in software development, integration, testing, operations, product management and project management at IBM and Nortel Networks. He holds a B.Sc. in Electrical Engineering, Electronics and Communication.
Dr. Bannis has been actively using telemedicine for patients’ care and remote patient monitoring for the last 5 years.
He acts as the lead medical advisor to the 2MDOpinion team and is a consulting doctor for primary and second medical opinion services.
Investor Invitation
Every family, at one time or another, has to deal with a serious medical condition with a family member. We offer the technology and service to connect with medical expertise that can be trusted with a professional second opinion.
Use of Proceeds
If the offering's maximum amount of $1,000,000 is raised:
| Use | Value | % of Proceeds |
|---|---|---|
| Unallocated Funds | $951,000 | 95.1% |
| Employee compensation | $440,000 | 44.0% |
| Development and Support | $307,278 | 30.7% |
| Marketing expenses | $106,365 | 10.6% |
| Asset operating expenses | $97,357 | 9.7% |
| Intermediary fees | $49,000 | 4.9% |
Terms
This number includes all funds raised by the Company in this round on Netcapital. This is an offering of Common Stock, under registration exemption 4(a)(6), in 2MDOpinion, Inc.. This offering must reach its target of at least $10,000 by its offering deadline of April 1, 2025 at 11:59pm ET. If this offering does not reach its target by the offering deadline, then your money will be refunded.
If the offering is successful at raising the maximum amount, then the company’s implied valuation after the offering (sometimes called its post-money valuation) will be:
Financials
These financial statements have been reviewed by an independent Certified Public Accountant.
SEC Filings
The Offering Statement is a formal description of the company and this transaction. It’s filed with the SEC to comply with the requirements of exemption 4(a)(6) of the Securities Act of 1933.
We’re also required to share links to each of the SEC filings related to this offering with investors.
Understand the Risks
Be sure to understand the risks of this type of investment. No regulatory body (not the SEC, not any state regulator) has passed upon the merits of or given its approval to the securities, the terms of the offering, or the accuracy or completeness of any offering materials or information posted herein. That’s typical for Regulation CF offerings like this one.
Neither Netcapital nor any of its directors, officers, employees, representatives, affiliates, or agents shall have any liability whatsoever arising from any error or incompleteness of fact or opinion in, or lack of care in the preparation or publication of, the materials and communication herein or the terms or valuation of any securities offering.
The information contained herein includes forward-looking statements. These statements relate to future events or to future financial performance, and involve known and unknown risks, uncertainties, and other factors, that may cause actual results to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties, and other factors, which are, in some cases, beyond the company’s control and which could, and likely will, materially affect actual results, levels of activity, performance, or achievements. Any forward-looking statement reflects the current views with respect to future events and is subject to these and other risks, uncertainties, and assumptions relating to operations, results of operations, growth strategy, and liquidity. No obligation exists to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
More Info
Updates
- Mar 9, 2025TCE Group (founder of 2MDopinion) among 18...
- Mar 9, 2025We thank Robin Arthur Joffe, Partner - Managing...
- Feb 9, 2025TCE Group meeting with prospective business...
- Feb 2, 2025Founders of 2MDopinion signed a dynamic...
- Feb 2, 2025The Founders of 2MDopinion participated in Arab...
Ask a Question
Proofread your comment before submitting: once it's posted, you can’t edit or delete it. Investors are advised to review our Discussion Board Policy before submitting a comment. For the fastest help with the web site, email help@netcapital.com instead of commenting.
Looking to raise capital?
We can help turn your friends, family and customers into investors.
Interested in more investment opportunities?
Browse all offerings currently available.